常山药业：关于控股股东部分股票解除质押的公告

Group 1 - The core point of the article is that Changshan Pharmaceutical announced the release of 56,206,500 shares from pledge by its controlling shareholder, Gao Shuhua [2] Group 2 - The announcement was made on January 23, indicating a significant change in the shareholding structure [2] - The release of shares from pledge may reflect the controlling shareholder's confidence in the company's future performance [2] - This action could potentially impact the stock's liquidity and investor sentiment towards Changshan Pharmaceutical [2]